Tuberculous meningitis can be caused either by miliary spread or by a rupture of the meningeal tuberculoma that results from an earlier hematogenous seeding of tubercle bacilli from a pulmonary focus. The onset of the malady is usually gradual with the patient presenting with fever, anorexia, irritability, and listlessness followed by coma, convulsions, vomiting, and headache. In older patients, behavioral changes and headache are prominent early symptoms. Cranial nerve palsies and nuchal rigidity also occur as the meningitis progresses. A prior history of tuberculosis or evidence of active tuberculosis is present in about three out of four patients. In diagnosing the patient, the spinal fluid is often yellowish with increased pressure, contains more protein than usual and less glucose than usual, and has a lymphocyte cell count around 100-500 cells/mcL. In treating the disease, presumptive diagnosis followed by early, empiric antituberculosis is critical to ensure the patient’s survival. Even if the patient’s cultures are not positive, a full course of therapy is warranted if the clinical setting is suggestive of tuberculous meningitis. Regimes that are effective for pulmonary tuberculosis are also effective for tuberculous meningitis. Many authorities, though, recommend the addition of corticosteroids for patients with focal deficits or altered mental status. The drug of choice here is Dexamethasone (.15 mg/kg administered intravenously or orally five times a day for one to two weeks).